The Journal of Thoracic and Cardiovascular Surgery
Volume 129, Issue 2 , Pages 429-434, February 2005

Effects of postmortem heparinization in canine lung transplantation with non–heart-beating donors

Department of Cancer and Thoracic Surgery (Surgery II), Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan

Received 3 February 2004; received in revised form 2 May 2004; accepted 6 May 2004.

Objective

Microthrombus formation appears to be one of the major detrimental factors in lung transplantation from non–heart-beating donors. The purpose of this study was to evaluate the effects of postmortem heparinization by closed-chest cardiac massage in a canine model of left single-lung allotransplantation from non–heart-beating donors.

Methods

Left lung transplantation was performed in 18 weight-matched pairs of mongrel dogs. Donors were killed with an intravenous injection of potassium chloride and left at room temperature for 2 hours. The cadaveric donors were assigned randomly to one of the three groups. In group 1 (n = 6), no heparin was given as a control. In group 2 (n = 6), heparin sodium (1000 U/kg) was administered intravenously before cardiac arrest. In group 3 (n = 6), heparin sodium (1000 U/kg) was administered intravenously 10 minutes after death, then closed-chest cardiac massage was performed for 2 minutes. After 2 hours of cardiac arrest, donor lungs were flushed with low-potassium dextran-glucose solution and preserved for 60 minutes. After left lung transplantation, the right pulmonary artery was ligated, and recipient animals were followed up for 3 hours. Univariate and multivariate repeated analyses were used for statistics.

Results

Both groups 2 and 3 had significantly better gas exchange and lower pulmonary vascular resistance than group 1. Changes in thrombin-antithrombin III complex concentration during the warm ischemia indicated that postmortem heparinization suppressed clotting activation in the donor.

Conclusions

Postmortem heparinization by cardiac massage is beneficial in lung transplantation from non–heart beating donors by preventing microthrombus formation.

 

 Supported by the Research Grant for Cardiovascular Diseases (12C-6) from the Ministry of Health, Labor and Welfare, Japan.

PII: S0022-5223(04)00773-1

doi:10.1016/j.jtcvs.2004.05.009

The Journal of Thoracic and Cardiovascular Surgery
Volume 129, Issue 2 , Pages 429-434, February 2005